Cetide 0.25 mg Injection

Manufactured byLg Lifesciences
ContainsCetrorelix
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

Cetide 0.25 mg Injection is used along with other hormonal medicines such as human chorionic gonadotropin (hCG) in women who are under fertility treatment (controlled ovarian stimulation) for preventing the release of a premature egg from the ovary. Use of this medicine in pregnant women is not recommended.

Side effects

Major & minor side effects for Cetide 0.25 mg Injection

  • Hypersensitivity
  • Ovarian hyperstimulation syndrome (OHSS)
  • Nausea
  • Headache
  • Swelling of ankles or feet
  • Decreased urine output
  • Shortness of breath
  • Rapid weight gain

Uses of Cetide 0.25 mg Injection

What is it prescribed for?

  • Prevention of premature ovulation in women undergoing controlled ovarian stimulation
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 1 hour of administration of the 3 mg dose and within 2 hours of administration of the 0.25 mg dose.
  • Duration of effect
    Cetide 0.25 mg Injection remains active in the body for 24 hours after a 0.25 mg dose and for 4 days after a 3 mg dose.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women.

Allergy

This medicine is not recommended for use in patients with a known allergy to cetrorelix or any other components present along with it.

Pregnancy

This medicine is not recommended for use in pregnant women.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women.
General warnings

Use in pediatrics

This medicine is not recommended for use in children and adolescents.

Elevated liver enzymes

This medicine may cause elevation of liver enzymes up to 3 times of the upper limit of normal. Close monitoring of liver enzymes is recommended during treatment with this medicine.

Geriatric use

Cetide 0.25 mg Injection is not recommended for use in patients above 65 years of age.

Missed Dose

If you miss an appointment for a dose of Cetide 0.25 mg Injection injection, contact your doctor immediately and schedule the dose as soon as possible.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Cetide 0.25 mg Injection injection is usually administered by a qualified healthcare professional. Follow all the instructions given by your doctor. Consult the doctor if you experience any undesirable effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Cetide 0.25 mg Injection acts by blocking the action of certain natural hormones responsible for the release of an egg from the ovary. This helps in preventing the premature release of the egg.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Gonadotropin releasing hormone (GnRH) antagonist

Schedule

N/A

CETROTIDE - cetrorelix acetate [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 21 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79&audience=consumer

[Internet]. 2017 [cited 21 August 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/8744

Cetrorelix - DrugBank [Internet]. Drugbank.ca. 2017 [cited 21 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00050

Cetrorelix (substance) [Internet]. Snomedbrowser.com. 2017 [cited 21 August 2017]. Available from:

http://www.snomedbrowser.com/Codes/Details/395906005

[Internet] Genome.jp. 2017 [cited 21 August 2017]. Available from:

http://www.genome.jp/dbget-bin/www_bfind_sub?mode=bfind&max_hit=1000&dbkey=all&keywords=cetrorelix
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error